About Indian Immunologicals Limited
Data last updated:
Indian Immunologicals Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of National Dairy Development Board. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 08 October 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72200TG1999PLC032666. Its GSTIN is 36AAACI6620F1ZV (Telangana). The company holds 19 GST registrations, of which 16 are active.
The company has an authorised share capital of ₹400 Cr and a paid-up capital of ₹54 Cr. It is led by directors including Anand Kumar Kanakasapapathy (Managing Director) and Meeneshkumar Champaklal Shah.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indian Immunologicals Limited Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,512.93 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹473.39 Cr (net margin 31.3%) and EBITDA of ₹703.12 Cr (EBITDA margin 46.5%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 11% over five years.
The company is associated with 1 brand: Indian Immunologicals. As per MCA filings, the company has open charges of ₹335.16 Cr and satisfied charges of ₹887.42 Cr on record. Court records list 124 cases involving the company, including 67 filed by the company and 60 filed against it; 18 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indimmune.com.
Company details
CIN history
Indian Immunologicals has one previous CIN (Corporate Identification Number): U72200AP1999PLC032666. The current CIN is U72200TG1999PLC032666, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200TG1999PLC032666 | Current |
| U72200AP1999PLC032666 | Previous |
Contact details
Indian Immunologicals Limited's registered office is in Hyderabad, Telangana. Its website is indimmune.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressIndian Immunologicals Limited Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Indian Immunologicals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Indian Immunologicals operates one associated brand: Indian Immunologicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Vaccines for animal and human health are manufactured. | indimmune.com |
Business activity
The main business activity of Indian Immunologicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indian Immunologicals Limited, buy the company report.
Financials of Indian Immunologicals Limited
FY 2025 filings availableIndian Immunologicals Limited reported revenue of ₹1,512.93 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 8% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹703.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹473.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 46.5% | ||||
| Net Profit Margin | 31.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indian Immunologicals Limited, buy the company report.
Board of directors of Indian Immunologicals Limited
Indian Immunologicals has 7 current directors and 27 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meeneshkumar Champaklal Shah Also directs: North East Dairy and Foods Limited, NDDB Mrida Limited, NDDB Dairy Services and 4 more | Director | 15 Jul 2021 | 5 Years 3 Months | Current |
| Rajeev Sivarama Also directs: North East Dairy and Foods Limited, NDDB Mrida Limited, Mother Dairy Fruit and Vegetable Private Limited and 1 more | Director | 06 Aug 2021 | 5 Years 2 Months | Current |
| Anand Kumar Kanakasapapathy Also directs: Veterinary Vaccine India Manufacturers Association | Managing Director | 01 Nov 2013 | 12 Years 11 Months | Current |
| Usha Ramachandra Also directs: Integrum Energy Infrastructure Limited | Director | 18 Mar 2025 | 1 Years 7 Months | Current |
| Devanand Chakkingal Pathayapura | Director | 12 Nov 2021 | 4 Years 11 Months | Current |
| Venkateswara Rao Thallapaka | Director | 18 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Indian Immunologicals Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viyash Scientific Limited | ₹1,566.06 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| Indian Immunologicals Limitedthis company | ₹1,512.93 Cr (FY 2025) | ₹473.39 Cr | 31.3% | 8.0% | Hyderabad, Telangana, India | |
| Natural Remedies Private Limited | ₹548.65 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Fredun Pharmaceuticals Ltd | ₹456.27 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Indian Immunologicals Limited, buy the company report.
Auditor
Indian Immunologicals Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2022 | 117366W/W - 100018 |
Shareholding
The shareholding of Indian Immunologicals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Indian Immunologicals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 May 2016 | 100031486 | Others | ₹5 Cr | Open | |
| 18 Mar 2016 | 100024550 | Others | ₹85.16 Cr | Open | |
| 12 Dec 2013 | 10470895 | Others | ₹40 Cr | Open | |
| 14 Dec 2011 | 10327282 | Others | ₹85 Cr | Open | |
| 02 Sep 2010 | 10242342 | Hdfc Bank Limited | ₹120 Cr | Open |
To see the full charge records of Indian Immunologicals Limited, buy the company report.
Total charge records: 23 View all charges
Legal cases
Indian Immunologicals Limited has 124 court cases on record: 67 filed by Indian Immunologicals, 60 filed against it. 18 cases are pending and 106 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 108 | 47 | 16 |
| Supreme Court | 9 | 6 | 0 |
| District courts | 7 | 7 | 2 |
Cases on record (5 of 124)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0603-Service Matters : Removal/Dismissal/Termination from service or other major penalties) | Filed against the company by Indian Immunologicals Limited Hyderabad Rep. by Its Managing Director Road No. 44, Jubilee Hills, Hyderabad ,Hyderabad , Telangana and 3 others | Disposed |
| Supreme Court | Court case (0603-Service Matters : Removal/Dismissal/Termination from service or other major penalties) | Filed by the company against Narendra Agrawal S/D/W/Thru:- Late Shri Nathulal Chief Manager (M2)-Hr, (Under Orders of Termination), Indian Immunologicals Limited Currently Residing at B/413, Fresh Living Apartment, Madhapur, Hyderabad-81 ,Hyderabad , Telangana and 2 others | Disposed |
| High Court, TELANGANA | Appeal | Filed against the company by Indian Immunologicals Limited and 3 others | Disposed |
| High Court, TELANGANA | Appeal | Filed by the company against Chairman Audit Committee, Indian Immunologicals Limited and 2 others | Disposed |
| Supreme Court | Court case (4203-MATTERS RELATING TO LEASES, GOVT. CONTRACTS & CONTRACTS BY LOCAL BODIES : Tenders invited or contracts awarded/leases granted or determined by State Governments / Union Territories) | Filed against the company by Gujarat Medical Services Corporation Ltd. and Anr. Through General Manager Through General Manager Block No. 14/1, Dr. Jivraj Mehta Bhavan, Sector 10 , District: Gandhinagar ,Gandhinagar , Gujarat and 1 other | Disposed |
To see the full case history of Indian Immunologicals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Indian Immunologicals Limited was last rated by Crisil on 07 Aug 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 07 Aug 2019 |
To see the full credit ratings and regulatory alerts of Indian Immunologicals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indian Immunologicals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indian Immunologicals has 19 GST registrations: 16 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACI6620F1ZV | Telangana | Active | 01 Jul 2017 |
| 03AAACI6620F1Z4 | Punjab | Active | 01 Jul 2017 |
| 05AAACI6620F1Z0 | Uttarakhand | Active | 01 Jul 2017 |
| 06AAACI6620F1ZY | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Indian Immunologicals Limited, buy the company report.
Recent activity
Indian Immunologicals Limited has 34 board changes on record since 2008: 9 appointments and 25 cessations. The latest: Usha Ramachandra was appointed as Director on 18 Mar 2025.
75 earlier events are in the company report.
News
Frequently asked questions
Indian Immunologicals is an active public limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 08 October 1999 (27+ years old) and is registered under CIN U72200TG1999PLC032666.
Indian Immunologicals has 7 current directors:
- Anand Kumar Kanakasapapathy - Managing Director
- Meeneshkumar Champaklal Shah - Director
- Rajeev Sivarama - Director
- Usha Ramachandra - Director
- Devanand Chakkingal Pathayapura - Director
- Venkateswara Rao Thallapaka - Director
- Sanjay Madhav Mehendale - Director
The latest financial statements of Indian Immunologicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 12 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indian Immunologicals is 36AAACI6620F1ZV, registered in Telangana. The company has 19 GST registrations in all, of which 16 are active and 3 are cancelled or inactive. Other active GSTINs include 03AAACI6620F1Z4 (Punjab), 05AAACI6620F1Z0 (Uttarakhand), 06AAACI6620F1ZY (Haryana).
The CIN (Corporate Identification Number) of Indian Immunologicals is U72200TG1999PLC032666. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indian Immunologicals has 124 court cases on record: 67 filed by the company and 60 filed against it. 18 are pending. Most are in the high courts.
Indian Immunologicals was incorporated on 08 October 1999, making it 27+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Indian Immunologicals by revenue are Viyash Scientific Limited, Natural Remedies Private Limited, Fredun Pharmaceuticals Ltd, all in the Pharma industry (Animal Pharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Usha Ramachandra was appointed as Director on 18 Mar 2025. Usha Ramachandra ceased to be Additional Director on 18 Mar 2025. Venkateswara Rao Thallapaka was appointed as Director on 18 Mar 2025. Indian Immunologicals has 34 board changes on record in total.
Indian Immunologicals can be reached through the website indimmune.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Indian Immunologicals is at Indian Immunologicals Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033.